Concepedia

Jinjuan Wang

JW

Statistics

Publications

20

Citations

2.2K

H-Index

15

Active since

1998

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Beijing Obstetrics and Gynecology Hospital

Capital Medical University

City Of Hope National Medical Center

Jinjuan Wang is an author at Fred Hutch Cancer Center specializing in life sciences, cancer immunotherapy, and immunology.

ORCID

Publications per year

1998–2023

20

Publications

20

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Brian G. Till, Michael C. Jensen, Jinjuan Wang et al. · Blood · 2008 · 719 citations · Full text

, , +17

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Brian G. Till, Michael C. Jensen, Jinjuan Wang et al. · Blood · 2012 · 530 citations

, , +17

Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane

Scott E. James, Philip D. Greenberg, Michael C. Jensen et al. · The Journal of Immunology · 2008 · 251 citations · Full text

, , +17

Optimizing Adoptive Polyclonal T Cell Immunotherapy of Lymphomas, Using a Chimeric T Cell Receptor Possessing CD28 and CD137 Costimulatory Domains

Jinjuan Wang, Michael C. Jensen, Yukang Lin et al. · Human Gene Therapy · 2007 · 213 citations

, , +17

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

Lihua E. Budde, Carolina Berger, Yukang Lin et al. · PLoS ONE · 2013 · 189 citations · Full text

, , +17

1–5 of 20